Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 1,272.5525
Recommendation STRONG BUY
P/E 17.37
ROE 100.00 %
Capitalization 97,993,504,601 $
Dividend Yield 5.23 %
P/S 2.51
AII Position 4
P/E Position 165
ROE Position 23
Capitalization Position 91
Dividend Yield Position 71
Sales 30,186,000,000 £
10-Year Average Earnings 4,356,000,000 £
Shares Outstanding 4,941,000,000
Equity -68,000,000 £
Dividend per Share 0.8 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2017 12 30,186,000,000.00 £
2016 12 27,889,000,000.00 £
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2017 12 1,532,000,000.00 £
2016 12 912,000,000.00 £
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2017 12 -68,000,000.00 £
2016 12 1,124,000,000.00 £
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 4,941,000,000
2016 12 4,909,000,000
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000

 












Bloomberg News for GLAXOSMITHKLINE:



Google News for GLAXOSMITHKLINE:

Reuters - 3 days ago
Exclusive: Nestle, Unilever, Coke make bids in $4 billion-plus GSK ...
LONDON (Reuters) - Nestle (NESN.S), Unilever (ULVR.L) (UNc.AS) and Coca-Cola (KO.N) are among bidders for GlaxoSmithKline's (GSK.L) ...
Markets Insider
GSK grabs new drug development head from Boehringer
LONDON (Reuters) - GlaxoSmithKline <GSK.L> has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of ...
euronews - 3 days ago
Trelegy Ellipta Gets Positive CHMP Opinion Supporting Expanded ...
(RTTNews) - GlaxoSmithKline plc (GSK, GSK.L) and Innoviva Inc. (INVA) said that the European Medicines Agency's Committee for Medicinal ...
Markets Insider - 21 hours ago
Glaxosmithkline Plc (GSK.L) Money Flow Index Levels in Focus
The Money Flow Index of Glaxosmithkline Plc (GSK.L) this week has placed the shares on the radar as it nears the key 70 or 80 level.
Tremont Herald - 1 day ago
Drugmaker GSK to eliminate 650 US jobs
(Reuters) - British drugmaker GlaxoSmithKline Plc <GSK.L> said on Wednesday it would cut about 650 positions in the United States related to ...
Lakeland Observer
GSK says US FDA wants more information on pulmonary drug
LONDON (Reuters) - GlaxoSmithKline <GSK.L> said on Friday that U.S. health authorities had asked for more information about its Nucala ...
euronews - 5 Sep 2018
Nestle aims to shed skin unit to focus on food, nutrition
... Gerber Life Insurance business for $1.55 billion, while sources told Reuters it was also bidding for GlaxoSmithKline's (GSK.L) Horlicks drink.
euronews - 7 Sep 2018
Nestle puts skin health unit up for sale to focus on food, nutrition
... Gerber Life Insurance business for $1.55 billion, while sources told Reuters it was also bidding for GlaxoSmithKline's <GSK.L> Horlicks drink.
Reuters - 2 days ago
Coca-Cola moving ahead with takeover of Nigeria's Chi juice
... for $5.1 billion, and sources familiar with the matter say it is also bidding for GlaxoSmithKline's <GSK.L> Indian Horlicks nutrition business.
Daily Times - 22 hours ago
Coca-Cola buys Australia's kombucha maker Mojo
The company is also among the bidder for GlaxoSmithKline's <GSK.L> Indian Horlicks nutrition business, Reuters reported on Tuesday.


Back